For quite some time, the safest place for me to speak about my symptoms and health struggles was through a Facebook page or chat window. I’d send screenshots of scans, paste blood work results, and confess flare‑day fears at midnight. Those messages mattered; they validated the parts of me the…
Columns
In the diagnostic phase of my journey, I was learning that I had multiple conditions back to back. While some of these fell under the IgG4-related disease (IgG4-RD) branch and some overlapped with my Sjögren’s disease, the rest have their own standing when it comes to my list…
We often talk about the relief and hope we feel once we finally have a proper IgG4-RD diagnosis, and thus a name for our collection of symptoms. But we rarely talk about the battle that’s yet to come. When we learn we have IgG4-RD, we also learn that…
Living with IgG4-related disease can be overwhelming at times because of its unpredictable nature. Some fellow patients and I often joke about having to spin the wheel of IgG4-RD symptoms when we wake up in the morning, to see what we’ll have to face that day. Jokes aside, the…
After countless appointments, I still clung to a sliver of hope that my new doctors would be able to put a name to the various symptoms I was experiencing. But despite being riddled with pain, I was told that all of my scans and blood work looked normal. “There’s nothing…
For decades, my body was a puzzle that baffled even the most experienced doctors. A symphony of pain, fatigue, and other strange symptoms left specialists stumped. It took relentless self-advocacy, unwavering resilience, persistent determination, and countless hours of research to finally be diagnosed with Sjögren’s disease and Mikulicz’s disease (an…
Recent Posts
- ‘Watchful waiting’ may raise risk of relapse for those with mild IgG4-RD
- Guest Voice: My creativity was a lifeline before I had a diagnosis
- Rilzabrutinib awarded orphan drug status in Japan for IgG4-RD
- Shedding a light on hidden disabilities to improve understanding
- Long-term rituximab treatment safe, effective for IgG4-RD, new study finds
